Jeffrey Segal Net Worth & Insider Trades
Jeffrey Segal - Director, Invo Bioscience, Inc
What is Jeffrey Segal's Net Worth?
The current estimated net worth of Invo Bioscience, Inc's Director, Jeffrey Segal, is estimated to be about $494.59 . Jeffrey Segal owns about 28,220 units of Invo Bioscience, Inc common stock. In the last 2 years at Invo Bioscience, Inc, Jeffrey Segal has sold an estimated value of $0 worth.
What is Jeffrey Segal's Past Insider Trading?
Jeffrey Segal's largest purchase order was 9,211 units , worth over $8.75K on June 3, 2022. In total, Jeffrey Segal has made about 4 transactions over 2 years of their time at Invo Bioscience, Inc. Jeffrey Segal usually trades in January, with the busiest year in 2022.
Jeffrey Segal
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Jeffrey Segal's' Mailing Address?
- Mailing address is Invo Bioscience, Inc. 5582 Broadcast Court Sarasota FL 34240 FL
Invo Bioscience, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Steven Shum | 2020 | $260,000 | $75,000 | $67,093 | - | - | $402,093 |
| Steven Shum | 2019 | $73,166 | - | $17,750 | $1,256,163 | - | $1,347,079 |
| Michael Campbell | 2020 | $218,125 | $87,500 | $221,400 | $742,542 | - | $1,269,567 |
| Michael Campbell | 2019 | $171,354 | - | - | - | - | $171,354 |
| Debra Hoopes | 2020 | - | - | - | - | $106,544 | $106,544 |
| Debra Hoopes | 2019 | - | - | - | - | $69,759 | $69,759 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1417926/000149315221017920/def14a.htm
What are Invo Bioscience, Inc's Past Insider Trades?
Invo Bioscience, Inc's most recent insider trade came on June 3, 2022 by Steve Shum who bought 58,885 units worth $55.94K . In the last year, insiders at Invo Bioscience, Inc have sold an estimated value of $168.44K and bought an estimated value of $792.68K worth of shares. Insider trading is most common in January, with the busiest year in 2022. The most active traders at the company are Barbara Ryan, Director, Jeffrey Segal, Director, and Matthew K Szot, Director .
INVO Bioscience, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||